ADMA Biologics, Inc.
ADMA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $61 | $90 | $72 | $103 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $138 | $110 | $99 | $50 |
| Inventory | $197 | $191 | $172 | $170 |
| Other Curr. Assets | $7 | $8 | $9 | $8 |
| Total Curr. Assets | $403 | $400 | $352 | $331 |
| Property Plant & Equip (Net) | $79 | $66 | $66 | $63 |
| Goodwill | $4 | $4 | $4 | $4 |
| Intangibles | $0 | $1 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $74 | $79 | $81 | $84 |
| Other NC Assets | $9 | $9 | $8 | $6 |
| Total NC Assets | $166 | $159 | $159 | $157 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $569 | $558 | $511 | $489 |
| Liabilities | – | – | – | – |
| Payables | $24 | $30 | $21 | $20 |
| Short-Term Debt | $4 | $1 | $1 | $1 |
| Tax Payable | $0 | $3 | $7 | $3 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $29 | $41 | $25 | $30 |
| Total Curr. Liab. | $56 | $75 | $53 | $56 |
| LT Debt | $79 | $83 | $81 | $81 |
| Deferred Rev, NC | $1 | $1 | $2 | $2 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $1 | $1 | $2 |
| Total NC Liab. | $81 | $85 | $84 | $84 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $9 | $10 | $9 | $10 |
| Total Liabilities | $138 | $160 | $137 | $140 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$211 | -$247 | -$282 | -$309 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $642 | $646 | $655 | $658 |
| Total Equity | $431 | $398 | $373 | $349 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $569 | $558 | $511 | $489 |
| Net Debt | $22 | -$6 | $10 | -$21 |